UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
P P- P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 PA PB PC PD PE PF PG PH PI PK PL PM PN PO PP PQ PR PS PT PU PV PW PX PY
selected terms: 5,403 page 1 of 55

1. (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl Pyrrolidine Fumarate
[A synthetic ethanolamine with anticholinergic, sedative, and histamine H1 antagonistic properties. Clemastine fumarate blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial and gastrointestinal smooth muscles, including vasodilation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscles. This drug also prevents histamine-induced pain and itching of mucous membranes. ( NCI )] (UMLS (NCI) C0546858) =Organic Chemical; Pharmacologic Substance =CLEMASTINE;
=CLEMASTINE FUMARATE 0.67 MG/5ML;
CLEMASTINE FUMARATE 1.34 MG;
CLEMASTINE FUMARATE 2.68 MG;
51. 11pd
[Maxillary left canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553569) =Medical Device =Artificial dentition;
2. (+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate(1:1)
[The maleate salt form of dexchlorpheniramine, an alkylamine, and first-generation histamine antagonist with anti-allergic activity. Dexchlorpheniramine maleate competitively blocks H1 receptors, thereby preventing the actions of histamine on bronchial smooth muscle, capillaries and gastrointestinal (GI) smooth muscle. This prevents histamine-induced bronchoconstriction, vasodilation, increased capillary permeability, and GI smooth muscle spasms. ( NCI )] (UMLS (NCI) C0137440) =Organic Chemical; Pharmacologic Substance ;
=DEXCHLORPHENIRAMINE;
=DEXCHLORPHENIRAMINE MALEATE 2 MG/5ML;
DEXCHLORPHENIRAMINE MALEATE 2 MG;
DEXCHLORPHENIRAMINE MALEATE 4 MG;
DEXCHLORPHENIRAMINE MALEATE 6 MG;
52. 11pm
[Maxillary left canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553567) =Medical Device =Artificial dentition;
3. (-)-Phenylisopropylmethylpropynylamine
[The hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity. ( NCI )] (UMLS (NCI) C0700467) =Organic Chemical; Pharmacologic Substance =l-Deprenyl;
=SELEGILINE HYDROCHLORIDE 5 MG;
53. 12p
[Maxillary left first premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553571) =Body Part, Organ, or Organ Component =Artificial dentition;
4. (.+ -.)-p-Isobutylhydratropic acid
[nonsteroidal analgesic, antipyretic and anti-inflammatory agent that is a propionic acid derivative. ( CSP )] (UMLS (NCI) C0020740) =Organic Chemical; Pharmacologic Substance ;
=[CN100] ANALGESICS;
NSAIDs;
[CN850] ANTIPYRETICS;
benzoate;
Phenylpropionates;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC;
[CN104] NONSTEROIDAL ANTI-INFLAMMATORY ANALGESICS;
=IBUPROFEN 100 MG;
IBUPROFEN 100 MG/5ML;
IBUPROFEN 200 MG;
IBUPROFEN 300 MG;
IBUPROFEN 600 MG;
IBUPROFEN 800 MG;
IBUPROFEN 400 MG;
54. 12pd
[Maxillary left first premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553572) =Medical Device =Artificial dentition;
5. (p-Methoxyphenyl)trithiopropene
[A drug that may reduce the risk of development or progression of cancer. ( NCI )] (UMLS (NCI) C0002937) =Organic Chemical; Pharmacologic Substance
55. 12pm
[Maxillary left first premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553570) =Medical Device =Artificial dentition;
6. *Pressure (Partial)
(UMLS (HL7) C0030604) =Natural Phenomenon or Process ;
=Kind of quantity;
56. 13p
[Maxillary left second premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553574) =Body Part, Organ, or Organ Component =Artificial dentition;
7. 1,1',1"-phosphinothioylidynetrisaziridine
[alkylating agent used as an antineoplastic in the treatment of carcinoma of the breast, ovary, and bladder, malignant infusions and lymphomas. ( CSP )] (UMLS (NCI) C0039871) =Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance =[AN000] ANTINEOPLASTICS;
Organothiophosphorus Compounds;
Triethylenephosphoramide;
Aminoethylene;
Antineoplastic Alkylating Agent;
=THIOTEPA 15 MG
57. 13pd
[Maxillary left second premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553575) =Medical Device =Artificial dentition;
8. 1,10-(1,2-Phenylene)pyrene
[A yellowish, aromatic hydrocarbon consisting of six fused rings and produced by the incomplete combustion of organic matter. Indene[1,2,3-cd]pyrene is primarily found in certain foods, gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, soot and petroleum asphalt. This substance is used only for research purposes. Indene[1,2,3-cd]pyrene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0063458) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
58. 13pm
[Maxillary left second premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553573) =Medical Device =Artificial dentition;
9. 1,2,3-Propanetricarboxylic Acid, 2-hydroxy-, Gallium-(sup 67)Ga(1:1) Salt
[A radioactive salt of gallium used as a radiopharmaceutical. The exact mechanism of action is unknown, but gallium citrate Ga-67 has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of inflammation. Adequate blood supply is essential for delivery of gallium citrate Ga-67 to the lesion. Gallium citrate Ga-67 is used as a diagnostic tool in neoplastic disease and inflammatory lesions. (NCI05) ( NCI )] (UMLS (NCI) C0893383) Gallium 67 citrate;
Gallium Citrate Ga-67;
GALLIUM CITRATE, GA-67;
GALLIUM CITRATE,GA-67;
GALLIUM CITRATE,GA-67 PREPARATION =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =gallium citrate;
[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS =GALLIUM CITRATE,GA-67 2 MIL;
59. 14-3-3 Protein Tau
[Encoded by human YWHAQ Gene, 245-amino acid 27.8 kD YWHAQ Protein is a cytoplasmic homodimeric 14-3-3 family protein. 14-3-3 proteins are localized in neurons, and are axonally transported to the nerve terminals. 14-3-3 proteins may be present in other tissues as well. A probable multifunctional regulator of cell signaling processes, YWHAQ Protein strongly activates PKC and activates tyrosine and tryptophan hydroxylases in the presence of Ca(2+)/calmodulin-dependent protein kinase II. (Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1458135) 14-3-3 Protein T-Cell;
14-3-3 Protein Theta;
HS1 Protein;
Tyrosine 3/Tryptophan 5 -Monooxygenase Activation Protein, Theta Polypeptide;
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein, Theta Polypeptide;
YWHAQ;
YWHAQ Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
10. 1,2,3-Propanetriol
[1,2,3-trihydroxypropane, a key intermediate in glucose metabolism; also serves as the bridge between hydrophobic "tails" and hydrophilic "heads" of many membrane lipids; reagent is used as a water-soluble solvent and lubricant. ( CSP )] (UMLS (NCI) C0017861) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =[DE350] EMOLLIENTS;
sugar alcohol;
triose;
[OP106] OSMOTIC AGENTS, SYSTEMIC OPHTHALMIC;
[RS300] LAXATIVES, RECTAL;
[OP500] EYE WASHES/LUBRICANTS;
[OP900] OPHTHALMICS, OTHER;
=glyceryl trinitrate;
GLYCEROL,IODINATED;
thioglycerol;
GREEN SOAP;
AQUANIL LOTION;
MOISTUREL CREAM,TOP;
MOISTUREL More…
60. 14p
[Maxillary left first molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553577) =Body Part, Organ, or Organ Component =Artificial dentition;
11. 1,2,3-Propanetriyl Butanoate
[A triglyceride drug that may inhibit cell growth and induce cell differentiation. Differentiating agents may be effective in changing cancer cells back into normal cells. ( NCI )] (UMLS (NCI) C0077025) =Lipid; Pharmacologic Substance ;
61. 14pd
[Maxillary left first molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553578) =Medical Device =Artificial dentition;
12. 1,2-Propyleneimine
[A synthetic, flammable, volatile, colorless oily liquid that is soluble in water, ethanol and most organic solvents. Propylenimine is used in the United States exclusively as an intermediate, and its derivatives are used in the paper, textile, rubber and pharmaceutical industries. Due to its volatility, potential exposure could occur during production, packaging, or use of substances made with this liquid. The primary routes of potential human exposure to propylenimine are inhalation, ingestion and dermal contact. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0072231) =Organic Chemical; Hazardous or Poisonous Substance ;
62. 14pm
[Maxillary left first molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553576) =Medical Device =Artificial dentition;
13. 1,3-Propanediol, 2-((3-fluoranthenylmethyl)amino)-2-methyl-
(UMLS (NCI) C0100007) =Organic Chemical; Pharmacologic Substance ;
63. 15p
[Maxillary left second molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553580) =Body Part, Organ, or Organ Component =Artificial dentition;
14. 1,3-Propanediol, 2-Amino-2-(hydroxymethyl)-
[A member of the pyrrolo-pyrrole group of non-steroidal anti-inflammatory drugs (NSAID) with analgesic, anti-inflammatory, and anti-pyretic properties. Tromethamine inhibits both isoforms of cyclooxygenases (COX1 and COX2), thereby blocking the conversion of arachidonic acid to pro-inflammatory pro-prostaglandins. When inhibiting COX2, tromethamine may be effective in relieving pain and inflammation; when inhibiting COX1, this agent may produce unacceptable gastrointestinal side effects. ( NCI )] (UMLS (NCI) C0041175) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =propanediol;
[TN900] THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES, OTHER =Lodoxamide Tromethamine;
(1R,2S)-(1,2-Epoxypropyl)phosphonic Acid, compound with 2-Amino-2-(hydroxymethyl)-1,3-propanediol(1:1);
TEST;
TROMETHAMINE 18 GM;
TROMETHAMINE 36 GM;
TROMETHAMINE 1.2 MG;
TROMETHAMINE 1.21 MG/ML;
TROMETHAMINE 83 MCG/ML;
64. 15pd
[Maxillary left second molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553581) =Medical Device =Artificial dentition;
15. 1,3-Propanediol, 2-methyl-2-propyl-, Dicarbamate
[A carbamate derivate with hypnotic, anti-anxiety, sedative, anticonvulsant and some indirect muscle relaxant properties. Although the exact mechanism of meprobamate is largely unknown, it appears to act as a depressant at multiple sites in the central nervous system, mostly likely through the GABAergic neurotransmitter system, including the thalamus and limbic system. ( NCI )] (UMLS (NCI) C0025386) =Organic Chemical; Pharmacologic Substance ;
=carbamate;
[CN309] SEDATIVES/HYPNOTICS, OTHER =MEPROBAMATE 200 MG;
MEPROBAMATE 400 MG;
MEPROBAMATE 600 MG;
65. 15pm
[Maxillary left second molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553579) =Medical Device =Artificial dentition;
16. 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2)
[The phosphate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids. ( NCI )] (UMLS (NCI) C0055447) =Organic Chemical; Pharmacologic Substance =chloroquine;
=Chloroquine Hydrochloride;
CHLOROQUINE PHOSPHATE 250 MG;
CHLOROQUINE PHOSPHATE 500 MG
66. 16p
[Maxillary left third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553583) =Body Part, Organ, or Organ Component =Artificial dentition;
17. 1,4-Phenylenebis(methylene)selenocyanate
(UMLS (NCI) C0167369) =Organic Chemical; Pharmacologic Substance ;
67. 16pd
[Maxillary left third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553584) =Medical Device =Artificial dentition;
18. 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate
[A synthetic glucocorticoid receptor agonist that mimics the metabolic, anti-inflammatory, and immunosuppressive activity of the natural glucocorticoids. Amcinonide interacts with specific corticosteroid receptors and was internalized, which leads to binding of DNA and modification of gene expression. This results in synthesis of anti-inflammatory mediators while inhibiting synthesis of inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are achieved. ( NCI )] (UMLS (NCI) C0051556) =Steroid; Pharmacologic Substance =(11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;
[DE200] ANTI-INFLAMMATORY, TOPICAL =AMCINONIDE 0.1 %
68. 16pm
[Maxillary left third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553582) =Medical Device =Artificial dentition;
19. 1-(p-Acetylbenzenesulfonyl)-3-Cyclohexylurea
[A sulfonylurea with oral hypoglycemic properties that is used in the treatment of Type II diabetes mellitus. Acetohexamide lowers blood sugar by stimulating insulin release from the pancreas and increases the sensitivity of beta cells to glucose stimulus. This drug also increases the sensitivity of insulin receptors in muscle, liver, and adipose tissue thereby promoting glucose transport across cell membranes. This results in better controlled blood glucose levels. (NCI05) ( NCI )] (UMLS (NCI) C0000992) =Organic Chemical; Pharmacologic Substance ;
69. 17p
[Mandibular left third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553586) =Body Part, Organ, or Organ Component =Artificial dentition;
20. 1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride
[The hydrochloride salt form of hydroxyzine, a piperazine histamine H1-receptor antagonist with anti-allergic, antispasmodic, sedative, anti-emetic and anti-anxiety properties. Hydroxyzine hydrochloride blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. In addition, hydroxyzine hydrochloride crosses the blood-brain barrier and acts on the histamine H1-receptors in the central nervous system. (NCI05) ( NCI )] (UMLS (NCI) C0600110) =Organic Chemical; Pharmacologic Substance =HYDROXYZINE;
=HYDROXYZINE HYDROCHLORIDE 100 MG;
HYDROXYZINE HYDROCHLORIDE 25 MG;
HYDROXYZINE HYDROCHLORIDE 50 MG;
HYDROXYZINE HYDROCHLORIDE 50 MG/ML;
HYDROXYZINE HYDROCHLORIDE 10 MG;
HYDROXYZINE HYDROCHLORIDE 25 MG/ML;
HYDROXYZINE HYDROCHLORIDE 10 MG/5ML
70. 17p
[Proximal (short) arm of chromosome 17 ( NCI )] (UMLS (NCI) C0796349) Chromosome 17 Proximal Arm;
Chromosome 17 Short Arm;
Chromosome 17p =Nucleotide Sequence
21. 1-(p-Chlorophenyl)-5-isopropylbiguanide Hydrochloride
[The hydrochloride salt form of proguanil, a synthetic biguanide derivative of pyrimidine and an folate antagonist with antimalarial property. Upon hydrolysis, proguanil is converted to its active cyclic triazine metabolite, cycloguanil, by a cytochrome P450 dependent reaction. Cycloguanil selectively inhibits the bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) of plasmodium parasite, thereby disrupting deoxythymidylate synthesis and ultimately blocking DNA and protein synthesis in the parasite. ( NCI )] (UMLS (NCI) C0546856) =Organic Chemical; Pharmacologic Substance
71. 17p12
[A chromosome band present on 17p ( NCI )] (UMLS (NCI) C0796364) Chromosome 17p12 =Nucleotide Sequence
22. 1-(p-Hydroxyphenyl)-2-(1'-methyl-2'-phenoxy)ethylaminopropanol-1 Hydrochloride
[The hydrochloride salt of isoxsuprine, a benzyl alcohol derivative with vasodilator activity. The mechanism of action of isoxsuprine hydrochloride is controversial because this drug has beta-adrenergic agonist activities that are not reversed by beta-adrenergic blockers. Although stimulation of the beta adrenergic receptor increases blood flow to produce vasodilatation, this drug may also have direct effects on the contractility of smooth muscle. Isoxsuprine hydrochloride also causes relaxation of uterine smooth muscle and may also produce positive inotropic and chronotropic effects on the myocardium. ( NCI )] (UMLS (NCI) C0282213) =Organic Chemical; Pharmacologic Substance =ISOXSUPRINE;
=ISOXSUPRINE HYDROCHLORIDE 10 MG;
ISOXSUPRINE HYDROCHLORIDE 20 MG
72. 17pd
[Mandibular left third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553585) =Medical Device =Artificial dentition;
23. 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
[selective estrogen receptor modulator; it is agonist for bone tissue and cholesterol metabolism but antagonist in mammary and uterine tissues. ( CSP )] (UMLS (NCI) C0039286) =Organic Chemical; Pharmacologic Substance ;
=amine;
Antiestrogen;
stilbene;
selective estrogen receptor modulator;
[AN500] ANTINEOPLASTIC HORMONES;
=(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine;
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate;
[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone;
(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate
73. 17pm
[Mandibular left third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553587) =Medical Device =Artificial dentition;
24. 1-p-carboxy-3,3-dimethylphenyltriazine
(UMLS (NCI) C0088835) =Organic Chemical; Pharmacologic Substance
74. 18p
[Mandibular left second molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553589) =Body Part, Organ, or Organ Component =Artificial dentition;
25. 1-phenyl-2-diethyl-amino-1-propanone Hydrochloride
[A sympathomimetic amine structurally similar to amphetamine with anorexiant activity. Diethylpropion hydrochloride stimulates the central nervous system and increases the release of norepinephrine and dopamine from nerve terminals and inhibits their uptake. This suppresses appetite, increases motor activity, causes euphoria, mental alertness and excitement. This drug may also cause an increase in heart rate and blood pressure. Diethylpropion hydrochloride is used in the treatment of obesity. ( NCI )] (UMLS (NCI) C0282133) =Organic Chemical; Pharmacologic Substance ;
=DIETHYLPROPION;
=DIETHYLPROPION HYDROCHLORIDE 75 MG;
DIETHYLPROPION HYDROCHLORIDE 25 MG
75. 18pd
[Mandibular left second molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553588) =Medical Device =Artificial dentition;
26. 1-Phenyl-Methyl-2-Piperazinyl-1H-Benzimidazole Hydrochloride
[A drug that prevents or reduces nausea and vomiting. ( NCI )] (UMLS (NCI) C0758799) Lerisetron =Organic Chemical; Pharmacologic Substance ;
76. 18pm
[Mandibular left second molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553590) =Medical Device =Artificial dentition;
27. 1-Phosphatidylinositol 3-Kinase
[An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V(D)J recombination and cell cycle checkpoints. (from LocusLink) ( NCI )] (UMLS (NCI) C0044602) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
77. 19p
[Mandibular left first molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553592) =Body Part, Organ, or Organ Component =Artificial dentition;
28. 1-Phosphatidylinositol 3-Kinase
[Phosphoinositide-3-Kinase, Catalytic, Gamma Polypeptide, encoded by the PIK3CG gene, belongs to the PI3/PI4-kinase family of proteins. This protein is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. (from LocusLink) ( NCI )] (UMLS (NCI) C0285761) =Amino Acid, Peptide, or Protein; Enzyme ;
78. 19pd
[Mandibular left first molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553591) =Medical Device =Artificial dentition;
29. 1-Phosphatidylinositol Phosphodiesterase
[Encoded by human PLCG2 Gene, 1265-aa 148-kDa Phospholipase C Gamma 2 is a crucial enzyme that generates DAG and IP3 second messengers in the transmembrane signaling of ligand-activated growth factor receptors. Containing a PI-PLC X-box catalytic domain, a PI-PLC Y-box catalytic domain, a C2 domain, a PH domain, 2 SH2 domains, and an SH3 domain, PLCG2 phospholipase activity increases upon phosphorylation on tyrosine residues following activation of growth factor and immune system receptors. (NCI) ( NCI )] (UMLS (NCI) C1377870) 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Gamma 2;
EC 3.1.4.11;
Phosphatidylinositol-Specific Phospholipase C-Gamma;
Phosphoinositide Phospholipase C;
Phospholipase C Gamma 2;
Phospholipase C, Gamma 2 (Phosphatidylyinositol-specific);
Phospholipase C-Gamma-2;
PI-Specific PLC Gamma;
PLCG2;
PLC-Gamma-2;
PLC-IV =Amino Acid, Peptide, or Protein; Enzyme
79. 19pm
[Mandibular left first molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553593) =Medical Device =Artificial dentition;
30. 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta 3
[Expressed in many tissues by human PLCB3 Gene, 1234-aa 139-kDa membrane-bound Phospholipase C Beta 3 contains a catalytic PI-PLC X-box domain, a catalytic PI-PLC Y-box domain, and a C2 domain. Activated in response to stimulation by hormones, growth factors, neurotransmitters, and other ligands, PLCB3 is a key enzyme in initiating receptor-mediated signal transduction by mediating production of DAG and IP3 second messengers. (NCI) ( NCI )] (UMLS (NCI) C1377871) Phosphoinositide Phospholipase C;
Phospholipase C Beta 3;
Phospholipase C Beta 3, Phosphatidylinositol-Specific;
PLCB3;
PLC-Beta-3 =Amino Acid, Peptide, or Protein; Enzyme
80. 1p
[Maxillary right third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552210) =Medical Device =Artificial dentition;
31. 1-Phosphatidylinositol-4-Phosphate 5-Kinase
[Expressed ubiquitously (high in brain) by human PIP5K2A Gene (PtdIns(4)P-5-Kinase Family), 406-aa 46-kDa Phosphatidylinositol-4-Phosphate 5-Kinase Type II Alpha is a likely homodimer that catalyzes the phosphorylation of phosphatidylinositol-4-phosphate on the fifth hydroxyl of the myo-inositol ring to form phosphatidylinositol-4,5-biphosphate, the precursor to second messengers of phosphoinositide signal transduction pathways involved in regulation of secretion, cell proliferation, differentiation, and motility. PIP5K2A does not show homology to other kinases, but the protein does exhibit kinase activity. (NCI) ( NCI )] (UMLS (NCI) C1368110) 1-Phosphatidylinositol-4-Phosphate Kinase;
Diphosphoinositide Kinase;
Phosphatidylinositol-4-Phosphate 5-Kinase Type II Alpha;
PIP5K2A;
PIP5KII-Alpha;
PIPK;
PtdIns(4)P-5-Kinase;
Type II Phosphatidylinositol-4-Phosphate 5-Kinase 53 K;
=Amino Acid, Peptide, or Protein; Enzyme
81. 1p
[Proximal (short) arm of chromosome 1 ( NCI )] (UMLS (NCI) C1327810) Chromosome 1 Proximal Arm;
Chromosome 1 Short Arm;
Chromosome 1p =Nucleotide Sequence ;
32. 1-Phosphatidylinositol-4-Phosphate Kinase
[Abundantly expressed (6.3-kb mRNA) in many tissues, human PIP5K2B Gene (PtdIns(4)P-5-Kinase Family) encodes 416-aa plasma membrane targeted Phosphatidylinositol-4-Phosphate 5-Kinase Type II Beta, a homodimer 78% identical in sequence to PIP5K2A that catalyzes phosphorylation of phosphatidylinositol-4-phosphate on the fifth hydroxyl of the myo-inositol ring to form phosphatidylinositol-4,5-bisphosphate, precursor to second messengers of phosphoinositide signal transduction pathways involved in regulation of secretion, cell proliferation, differentiation, and motility. PIP5K isoforms possess almost no homology to kinase motifs in other phosphatidylinositol, protein, and lipid kinases. Conserved basic residues may form a dual specificity site for phosphatidylinositol 3- and 5-phosphates. PIP5K2B specifically interacts with the juxtamembrane region of TNFR1; PIP5K2B activity is increased by TNF-alpha. (NCI) ( NCI )] (UMLS (NCI) C1368108) Diphosphoinositide Kinase;
Phosphatidylinositol-4-Phosphate 5-Kinase Type II Beta;
PIP5KIIB;
PIPKII-Beta;
PTDINS(4)P-5-Kinase;
=Amino Acid, Peptide, or Protein; Enzyme
82. 1pd
[Maxillary right third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552209) =Medical Device =Artificial dentition;
33. 1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-
[A piperazinyl quinazoline receptor tyrosine kinase inhibitor with antineoplastic activity. Tandutinib inhibits the autophosphorylation of FLT3 (FMS-Like Tyrosine kinase-3), c-KIT and PDGF (platelet-derived growth factor) receptor tyrosine kinases, thereby inhibiting cellular proliferation and inducing apoptosis. ( NCI )] (UMLS (NCI) C1143028) Tandutinib;
=Organic Chemical; Pharmacologic Substance ;
83. 1pm
[Maxillary right third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552211) =Medical Device =Artificial dentition;
34. 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI)
[2-trifluoromethyl derivative of perphenazine, used in treatment of psychoses. ( CSP )] (UMLS (NCI) C0016368) =Organic Chemical; Pharmacologic Substance ;
=Phenothiazine;
[CN700] ANTIPSYCHOTICS;
[CN701] PHENOTHIAZINES/RELATED, ANTIPSYCHOTICS;
=Flufenazine Decanoate;
Fluphenazine Enanthate;
FLUPHENAZINE HYDROCHLORIDE;
Flufenazine Decanoate;
Fluphenazine Enanthate;
FLUPHENAZINE HYDROCHLORIDE
84. 2 PAM
[ ] (UMLS (CSP) C0071808) =Organic Chemical; Pharmacologic Substance ;
=Pralidoxime Compounds;
[AD900] ANTIDOTES/DETERRENTS, OTHER =Pralidoxime Chloride
35. 1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride
[The hydrochloride salt form of remifentanil, a synthetic anilidopiperidine derivative and short-acting opiate agonist with analgesic and anesthetic properties. Remifentanil selectively binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. ( NCI )] (UMLS (NCI) C0771827) Remifentanil Hydrochloride;
REMIFENTANIL HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=REMIFENTANIL;
=REMIFENTANIL HYDROCHLORIDE 1 MG;
REMIFENTANIL HYDROCHLORIDE 5 MG;
REMIFENTANIL HYDROCHLORIDE 2 MG
85. 2 propylvalerate
[fatty acid with anticonvulsant properties. ( CSP )] (UMLS (CSP) C0080356) =Lipid; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
2-Propylpentanoic Acid;
carboxylate;
=2-Propylpentanoic Acid Sodium Salt;
36. 1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, Hydrochloride
[The hydrochloride salt form of trihexyphenidyl, a synthetic, substituted piperidine with parasympatholytic activity used mostly in Parkinson's disease. Trihexyphenidyl hydrochloride antagonizes activities of acetylcholine via muscarinic receptors. This balances the cholinergic and dopaminergic activity in the basal ganglia leading to an improvement of classic Parkinson symptoms such as rigidity and tremor. In addition, triphexyphenidyl hydrochloride exerts a direct antispasmodic effect on smooth muscle. ( NCI )] (UMLS (NCI) C0003830) =Organic Chemical; Pharmacologic Substance
86. 2, 5-Piperazinedione, 3,6-bis-(5-chloro-2-piperidyl)-, dihydrochloride
(UMLS (NCI) C0888240) 2,5-Piperazinedione, 3, 6-bis(5-chloro-2-piperidinyl)-, dihydrochloride, [3S-[3.alpha.(2S*,5R*),6.alpha.(2S*,5R*)]]- (9CI);
PZD dihydrochloride, 3,6-bis(5-chloro-2-piperidinyl)-, dihydrochloride;
=Organic Chemical; Pharmacologic Substance
37. 1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, Chloride
[The chloride salt form of methacholine, a direct-acting cholinergic muscarinic agonist with bronchoconstrictive, miotic, vasodilator, and cardiac vagomimetic activity. Methacholine chloride acts directly on the muscarinic receptors in the heart, eye, and lung, thereby producing parasympathomimetic effects. ( NCI )] (UMLS (NCI) C0079829) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Methacholine Compounds;
METHACHOLINE =METHACHOLINE CHLORIDE 100 MG;
METHACHOLINE CHLORIDE 20 MG/ML;
METHACHOLINE CHLORIDE 0.25 %;
87. 2,2',2",2"'-[(4-Piperidinopyrimido[5,4-d-]pyrimidine-2,6-diyl)dinitrilo]tetraethanol
[A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic. ( MSH )] (UMLS (NCI) C0026523) =Organic Chemical; Pharmacologic Substance
38. 1-Propanol, 3,3'-, dimethanesulfonate (ester), hydrochloride
(UMLS (NCI) C0971903) 1-Propanol, 3,3'-Iminobis-, Dimethanesulfonate (Ester), Hydrochloride (9CI;
1-Propanol, 3,3'-iminobis-, dimethanesulfonate (ester), hydrochloride (9CI);
1-Propanol, 3,3'-iminodi-, dimethanesulfonate (ester), hydrochloride (8CI);
1-Propanol-3,3'-iminodidimethanesulfonatehydrochloride;
3, 3'-Dimesyloxydipropylamine HCl;
3, 3'-Dimesyloxydipropylamine hydrochloride;
3, 3'-Iminodi-1-propanol Di(methanesulfonate) HCl;
3, 3'-Iminodi-1-propanol di(methanesulfonate) hydrochloride;
3, 3'-Iminodi-1-propanol Dimethanesulfonate Ester HCl;
3, 3'-Iminodi-1-propanol dimethanesulfonate ester hydrochloride;
3,3'-Imidodi-1-propanol, Dimethanesulfonate (Ester) HCl;
3,3'-Imidodi-1-propanol, dimethanesulfonate (ester), hydrochloride;
Bis(3-mesyloxypropyl)amine HCl;
Bis(3-mesyloxypropyl)amine hydrochloride;
IPD hydrochloride =Organic Chemical; Pharmacologic Substance ;
88. 2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine Hydrochloride
[The hydrochloride salt form of bromodiphenhydramine, a synthetic ethanolamine with histamine H1 antagonistic and sedative properties. Bromodiphenhydramine hydrochloride blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. This drug also prevents histamine-induced pain and itching of mucous membranes. ( NCI )] (UMLS (NCI) C0304299) =Organic Chemical; Pharmacologic Substance ;
=Bromazine;
=BROMODIPHENHYDRAMINE HYDROCHLORIDE 3.75 MG;
BROMODIPHENHYDRAMINE HYDROCHLORIDE 12.5 MG/5ML;
39. 1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, Hydrochloride
[The hydrochloride salt form of propafenone with class 1C antiarrhythmic effects. Propafenone hydrochloride stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby reducing sodium influx required for the initiation and conduction of impulses in Purkinje and myocardial cells. This agent produces a marked depression of phase 0 and prolonged effective refractory period in the atrio-ventricular nodal and His-Purkinje tissue, resulting in a profound decrease in excitability, conduction velocity and automaticity, thereby counteracting atrial and ventricular arrythmias. ( NCI )] (UMLS (NCI) C0700465) =Organic Chemical; Pharmacologic Substance =PROPAFENONE;
=PROPAFENONE HYDROCHLORIDE 150 MG;
PROPAFENONE HYDROCHLORIDE 225 MG;
PROPAFENONE HYDROCHLORIDE 300 MG
89. 2-(2-Pyridyl)ethylidine-1,1-bisphosphonate
[A synthetic pyridinyl bisphosphonate with anti-resorptive activity. Although the exact mechanism of action has yet to be fully elucidated, piridronic acid likely binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate synthase, an enzyme that plays an important role in the mevalonate pathway. This inhibits the formation of isoprenoid metabolites that are substrates for protein prenylation. This prevents farnesylation and geranylgeranylation of proteins essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, piridronic acid decreases bone turnover and stabilizes the bone matrix. ( NCI )] (UMLS (NCI) C0045686) =Organophosphorus Compound; Pharmacologic Substance ;
40. 1-Propanone, 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-
[A substance that is used to treat depression, and to help people quit smoking. It belongs to the family of drugs called antidepressants. ( NCI )] (UMLS (NCI) C0085208) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
Propiophenones;
[CN609] ANTIDEPRESSANTS, OTHER;
=(+-)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone Hydrochloride;
BUPROPION 150 MG;
BUPROPION 200 MG;
BUPROPION 300 MG;
90. 2-(p-Aminobenzenesulfonamido)-5-methylthiadiazole
[A broad-spectrum sulfanilamide and a synthetic analog of para-aminobenzoic acid (PABA) with antibacterial property. Sulfamethizole competes with PABA for the bacterial enzyme dihydropteroate synthase, thereby preventing the incorporation of PABA into dihydrofolic acid, the immediate precursor of folic acid. This leads to an inhibition of bacterial folic acid synthesis and de novo synthesis of purines and pyrimidines, ultimately resulting in cell growth arrest and cell death. ( NCI )] (UMLS (NCI) C0038687) =Organic Chemical; Pharmacologic Substance =Sulfathiazoles;
[AM650] SULFONAMIDE/RELATED ANTIMICROBIALS =SULFAMETHIZOLE 250 MG;
SULFAMETHIZOLE 500 MG;
SULFAMETHIZOLE 0.5 GM;
SULFAMETHIZOLE 400 MG;
SULFAMETHIZOLE 800 MG;
41. 1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
[USP lists as a diagnostc aid for determination of pituitary function. ( CSP )] (UMLS (NCI) C0025876) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =pyridine;
ACTH inhibitor;
[DX900] DIAGNOSTICS, OTHER;
=METYRAPONE 250 MG
91. 2-(p-Aminophenyl)-2-ethylglutarimide
[USP lists as an antineoplastic and an "adrenocortical suppressant." ( CSP )] (UMLS (NCI) C0002555) =Organic Chemical; Pharmacologic Substance ;
42. 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-
[The hydrochloride salt of Dyclonine, an unclassified compound with local anesthetic effect. Dyclonine reversibly binds to activated sodium channels on the neuronal membrane, thereby decreasing the neuronal membrane's permeability to sodium ions, leading to an increased threshold for excitation. This reversibly stabilizes the membrane and inhibits depolarization, leading to the failure of a propagated action potential and subsequent conduction blockade. This results in a transient and reversible loss of sensation in a localized area of the body. ( NCI )] (UMLS (NCI) C0058831) =Organic Chemical; Pharmacologic Substance =Propiophenones;
[DE700] LOCAL ANESTHETICS, TOPICAL =1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride;
92. 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate
[The maleate salt form of brompheniramine, an alkylamine derivative and a histamine antagonist with anticholinergic and sedative properties. Brompheniramine maleate competes with histamine for the H1 receptor. This diminishes the actions of histamine on effector cells and decreases the histamine-mediated symptoms of allergic reaction such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle. ( NCI )] (UMLS (NCI) C0546853) =Organic Chemical; Pharmacologic Substance =BROMPHENIRAMINE;
=BROMPHENIRAMINE MALEATE 4 MG/5ML;
BROMPHENIRAMINE MALEATE 10 MG/ML;
BROMPHENIRAMINE MALEATE 12 MG;
BROMPHENIRAMINE MALEATE 6 MG;
BROMPHENIRAMINE MALEATE 2 MG/5ML;
BROMPHENIRAMINE MALEATE 4 MG;
BROMPHENIRAMINE MALEATE 2 MG;
43. 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride
[The hydrochloride salt of Dyclonine, an unclassified compound with local anesthetic effect. Dyclonine reversibly binds to activated sodium channels on the neuronal membrane, thereby decreasing the neuronal membrane's permeability to sodium ions, leading to an increased threshold for excitation. This reversibly stabilizes the membrane and inhibits depolarization, leading to the failure of a propagated action potential and subsequent conduction blockade. This results in a transient and reversible loss of sensation in a localized area of the body. ( NCI )] (UMLS (NCI) C0304455) =Organic Chemical; Pharmacologic Substance =1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-;
=DYCLONINE HYDROCHLORIDE 0.5 %;
DYCLONINE HYDROCHLORIDE 1 %;
DYCLONINE HYDROCHLORIDE 01 %
93. 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine Bimaleate
[An ethanolamine class of H1 antihistamines with mild antimuscarinic and sedative properties. Carbinoxamine diminishes the typical histaminergic effects on H1-receptors in bronchial smooth muscle, capillaries, and gastrointestinal smooth muscle, including vasodilation, bronchoconstriction, increased vascular permeability, pain, itching, and spasmodic contractions of gastrointestinal smooth muscle. Carbinoxamine maleate is used to provide symptomatic relieve of allergic symptoms. ( NCI )] (UMLS (NCI) C0304300) =Organic Chemical; Pharmacologic Substance ;
=CARBINOXAMINE;
=CARBINOXAMINE MALEATE 2 MG/ML;
CARBINOXAMINE MALEATE 4 MG;
CARBINOXAMINE MALEATE 4 MG/5ML;
CARBINOXAMINE MALEATE 8 MG;
44. 1-Pyrrolidineethanamine, beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, Monohydrochloride
[The hydrochloride salt form of bepridil, a calcium antagonist and class IV anti-arrhythmic agent. Bepridil hydrochloride blocks calcium entry through membranous calcium channels of coronary and peripheral vascular smooth muscle, thereby dilating coronary arteries and peripheral arterioles. This increases oxygen delivery and reduces oxygen requirements. This drug is used to treat chronic stable and variant angina pectoris. ( NCI )] (UMLS (NCI) C0770909) Bepridil Hydrochloride;
BEPRIDIL HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =Bepridil;
=BEPRIDIL HYDROCHLORIDE 300 MG;
BEPRIDIL HYDROCHLORIDE 200 MG
94. 2-(Propylamino)-o-propionotoluidide Hydrochloride
[The hydrochloride salt form of prilocaine, an intermediate-acting local anesthetic of the amide type chemically related to lidocaine. Prilocaine hydrochloride binds to voltage-gated sodium ion channels in the neuronal membrane, thereby preventing the permeability of sodium ions. This leads to a stabilization of the neuronal membrane and inhibits depolarization and results in a reversible blockage of nerve impulse generation and propagation along nerve fibres and subsequent reversible loss of sensation. ( NCI )] (UMLS (NCI) C0008846) =Organic Chemical; Pharmacologic Substance =6,7-Epoxytropine Tropate;
=PRILOCAINE HYDROCHLORIDE 4 %;
45. 10-(2-Propynyl)estr-4-ene-3,17-dione
(UMLS (NCI) C0044695) =Steroid; Pharmacologic Substance ;
95. 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
[A phenazine dye with anti-mycobacterial and anti-inflammatory activity. The exact mechanism through which clofazime exerts its effect is unknown. However, it binds preferentially to mycobacterial DNA, thereby inhibiting DNA replication and cell growth. Clofazimine has a slow bactericidal effect on Mycobacterium leprae and is active against various other Mycobacteria. ( NCI )] (UMLS (NCI) C0008996) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =phenazine;
[AM900] ANTI-INFECTIVES, OTHER =CLOFAZIMINE 50 MG;
46. 10-Propargyl-10-Deazaaminopterin
[A substance that is being studied as an anticancer drug. It belongs to the family of drugs called folate analogues. ( NCI )] (UMLS (NCI) C0879404) PDX =Organic Chemical; Pharmacologic Substance ;
96. 2-Phenyl-1,3-propanediol Dicarbamate
[A propanediol compound with anticonvulsant and antiepileptic properties. Although the exact mechanism of action is unknown, Felbamate may be an antagonist at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate (NMDA) receptor-ionophore complex, thereby blocking the effects of the excitatory amino acids, suppressing neuronal firing, and preventing seizure activity. Felbamate also has weak inhibitory effects on gamma-aminobutyric acid (GABA) receptor binding sites which may contribute to its inhibitory effect on neuronal excitatory. ( NCI )] (UMLS (NCI) C0060135) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
propanediol =felbamate 120 MG/ML;
FELBAMATE 600 MG;
FELBAMATE 400 MG;
47. 10p
[Maxillary left lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553565) =Body Part, Organ, or Organ Component =Artificial dentition;
97. 2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate
(UMLS (NCI) C0054434) =Organic Chemical; Pharmacologic Substance ;
48. 10pd
[Maxillary left lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553566) =Medical Device =Artificial dentition;
98. 2-Phenylethylhydrazine Hydrogen Sulphate
[A hydrazine derivative and a potent non-selective monoamine oxidase (MAO) inhibitor with anxiolytic and antidepressant properties. Phenelzine sulfate irreversibly binds to MAO, thereby blocking the oxidative deamination of monoamines resulting in an increased concentration of biogenic amines and a concurrent decrease in catabolism of monoamine neurotransmitters, norepinephrine and serotonin, in the brain. In addition, through its primary metabolite phenylethylidenehyrazine (PEH), phenelzine causes elevated GABA levels in the caudate-putamen and nucleus accumbens thereby exerting its anxiolytic effects. ( NCI )] (UMLS (NCI) C0031393) =Organic Chemical; Pharmacologic Substance ;
=PHENELZINE;
=PHENELZINE SULFATE 15 MG
49. 10pm
[Maxillary left lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553564) =Medical Device =Artificial dentition;
99. 2-Piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (alphaR,2R)-
[A synthetic sympathomimetic amine with CNS stimulating properties. Dexmethylphenidate hydrochloride acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibits their uptake. This leads to an increase in motor activity, causes euphoria, mental alertness and excitement and suppresses appetite. This drug causes dependence and may cause an increase in heart rate and blood pressure. It is used in the treatment of attention deficit hyperactivity disorder. It may also be used in the treatment of fatigue and other nervous system effects seen with chemotherapy. ( NCI )] (UMLS (NCI) C1170743) DEXMETHYLPHENIDATE HYDROCHLORIDE;
d-threo-Methylphenidate Hydrochloride =Organic Chemical; Pharmacologic Substance
50. 11p
[Maxillary left canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553568) =Body Part, Organ, or Organ Component =Artificial dentition;
100. 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate Hydrochloride
[The hydrochloride salt form of flavoxate, a parasympatholytic agent with antispasmodic activity. Flavoxate hydrochloride competitively binds to muscarinic receptors, thereby preventing the actions of acetylcholine. This relaxes vascular smooth muscle, mainly of the urinary tract, and prevents smooth muscle contractions. ( NCI )] (UMLS (NCI) C0546865) =Organic Chemical; Pharmacologic Substance =FLAVOXATE;
=FLAVOXATE HYDROCHLORIDE 100 MG;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM